Sara Wahlin – Research output — Lund University

Emailsara.wahlinmed.luse

If you made any changes in Pure these will be visible here soon.

4 Article

4 results

Filter

2022
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
Wahlin, S., Boman, K., Moran, B., Nodin, B., Gallagher, W. M., Karnevi, E. & Jirström, K., 2022, In: BMC Cancer. 22, 1, 131.
Research output: Contribution to journal › Article › peer-review

Open Access
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
Olsson Hau, S., Wahlin, S., Cervin, S., Falk, V., Nodin, B., Elebro, J., Eberhard, J., Moran, B., Gallagher, W. M., Karnevi, E. & Jirström, K., 2022, In: Journal of Pathology: Clinical Research. 8, 1, p. 65-77
Research output: Contribution to journal › Article › peer-review

Open Access
2020
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: Implications for risk stratification of bladder cancer
Andersson, N., Ohlsson, J., Wahlin, S., Nodin, B., Boman, K., Lundgren, S. & Jirström, K., 2020 Oct 7, In: Biomarker research. 8, 1, 51.
Research output: Contribution to journal › Article › peer-review

Open Access
2019
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
Wahlin, S., Nodin, B., Leandersson, K., Boman, K. & Jirström, K., 2019, In: OncoImmunology. 8, 11, e1644108.
Research output: Contribution to journal › Article › peer-review

Open Access